DUSP16 Antibody
Description
Introduction to DUSP16 Antibody
The DUSP16 antibody is a research tool designed to detect the expression and activity of Dual Specificity Phosphatase 16 (DUSP16), a mitogen-activated protein kinase (MAPK) phosphatase that regulates JNK and p38 signaling pathways . This antibody is critical in studying DUSP16's role in cellular processes, including apoptosis, chemoresistance, and immune regulation.
Cancer Chemoresistance
DUSP16 antibodies were pivotal in identifying DUSP16 as a marker of chemoresistance. Overexpression of DUSP16 in cancer cells (nasopharyngeal, colorectal, gastric, breast) correlates with reduced apoptosis under chemotherapy, mediated by JNK/p38 inhibition . Patient survival analyses in head/neck and breast cancers confirm DUSP16 as a prognostic marker .
Immune Regulation
In T-cell differentiation, DUSP16 antibodies revealed its selective expression in Th2 cells, regulating IL-4/GATA-3 production and suppressing Th1 cytokines (IFN-γ) . Transgenic mouse studies linked DUSP16 to IgG subclass modulation, affecting humoral immunity .
Epigenetic Regulation
Methylation of the DUSP16 promoter silences its expression in Burkitt lymphoma (BL), enhancing JNK activation and sensitivity to anthracyclines . Antibody-based assays demonstrated restored DUSP16 expression after demethylation therapy .
Experimental Validation
Protocols for WB and IHC are optimized for DUSP16 detection . For WB:
-
Lyse cells in RIPA buffer.
-
Resolve proteins on 10% SDS-PAGE.
-
Block membranes with 5% skim milk.
-
Incubate with DUSP16 antibody (1:1000) at 4°C overnight.
Clinical and Diagnostic Potential
DUSP16 antibodies enable biomarker discovery in oncology. High expression levels correlate with poor prognosis in platinum-treated cancers , suggesting utility in therapy response prediction.
